Study on Bioequivalence of Trimetazidine Hydrochloride Sustained Release Tablets in Healthy Subjects

Feng Qiaoqiao, Ji Hongying, Liang Rui, Fan Hongyan, Wen Qing

Chinese Pharmaceutical Affairs ›› 2023, Vol. 37 ›› Issue (8) : 954-960.

Chinese Pharmaceutical Affairs ›› 2023, Vol. 37 ›› Issue (8) : 954-960. DOI: 10.16153/j.1002-7777.2023.08.013

Study on Bioequivalence of Trimetazidine Hydrochloride Sustained Release Tablets in Healthy Subjects

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 37(8): 954-960 https://doi.org/10.16153/j.1002-7777.2023.08.013

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉